Dried blood spot proteome identifies subclinical interferon signature in neonates with type I interferonopathy
Journal of Allergy and Clinical Immunology · 2025
DOI: 10.1016/j.jaci.2025.04.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Hiroshi Nihira und 36 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Pediatrics, Kyoto Okamoto Memorial Hospital, Kuse…. Hauptthemen laut MEDLINE: Dried Blood Spot Testing, Genetic Diseases, Inborn, Immune System Diseases, Interferon Type I. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
BACKGROUND: Type I interferonopathy is characterized by aberrant upregulation of type I interferon signaling. The mRNA interferon signature is a useful marker for activation of the interferon pathway and for diagnosis of type I interferonopathy; however, early diagnosis is challenging. OBJECTIVE: This study sought to identify the proteomic interferon signature in dried blood spot (DBS) samples. The aim was to evaluate the usefulness of the interferon signature for neonatal screening and to gain insight into presymptomatic state of neonates with inborn errors of immunity (IEIs). METHODS: DBS samples from healthy newborns/adults, patients with type I interferonopathy or other IEIs as well as from neonates with viral infections, including some samples obtained during the presymptomatic neonatal period, were examined by nontargeted proteome analyses. Expression of interferon-stimulated genes (ISGs) was evaluated and a DBS-interferon signature was defined. Differential expression/pathway analysis was also performed. RESULTS: The ISG products IFIT5, ISG15, and OAS2 were detected. Expression of IFIT5 and ISG15 was upregulated significantly in individuals with type I interferonopathy. We defined the sum of the z scores for these as the DBS-interferon signature, and found that patients with IEIs other than type I interferonopathy, such as chronic granulomatous disease (CGD), also showed significant elevation. Additionally, neonatal samples of type I interferonopathy and CGD patients showed high interferon signatures. Pathway analysis of neonatal CGD samples revealed upregulation of systemic lupus erythematosus-like pathways. CONCLUSION: Upregulation of the interferon pathway exists already at birth-not only in neonates with type I interferonopathy but also in other IEIs, including CGD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Pediatrics, Kyoto Okamoto Memorial Hospital, Kuse, Japan.
- Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japan.
- Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: kizawa@kuhp.kyoto-u.ac.jp.
- Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japan. Electronic address: ykawashi@kazusa.or.jp.
- Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Department of Pediatrics, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Ministry of Health, Labour and Welfare
Zitieren
APA
Nihira, H., Nakajima, D., Izawa, K., Kawashima, Y., Shibata, H., Konno, R., Higashiguchi, M., Miyamoto, T., Nishitani-Isa, M., Hiejima, E., Honda, Y., Matsubayashi, T., Ishihara, T., Yashiro, M., Iwata, N., Ohwada, Y., Tomotaki, S., Kawai, M., Murakami, K., …, & Yasumi, T. (2025). Dried blood spot proteome identifies subclinical interferon signature in neonates with type I interferonopathy. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.04.025
Vancouver
Nihira H, Nakajima D, Izawa K, Kawashima Y, Shibata H, Konno R, et al. Dried blood spot proteome identifies subclinical interferon signature in neonates with type I interferonopathy. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.04.025
BibTeX
@article{Nihira2025,
author = {Nihira, Hiroshi and Nakajima, Daisuke and Izawa, Kazushi and Kawashima, Yusuke and Shibata, Hirofumi and Konno, Ryo and Higashiguchi, Motoko and Miyamoto, Takayuki and Nishitani-Isa, Masahiko and Hiejima, Eitaro and Honda, Yoshitaka and Matsubayashi, Tadashi and Ishihara, Takashi and Yashiro, Masato and Iwata, Naomi and Ohwada, Yoko and Tomotaki, Seiichi and Kawai, Masahiko and Murakami, Kosaku and Ohnishi, Hidenori and Ishimura, Masataka and Okada, Satoshi and Yamashita, Motoi and Morio, Tomohiro and Hoshino, Akihiro and Kanegane, Hirokazu and Imai, Kohsuke and Nakamura, Yasuko and Nonoyama, Shigeaki and Uchiyama, Toru and Onodera, Masafumi and Ishikawa, Takashi and Kawai, Toshinao and Takita, Junko and Nishikomori, Ryuta and Ohara, Osamu and Yasumi, Takahiro},
title = {Dried blood spot proteome identifies subclinical interferon signature in neonates with type I interferonopathy},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
doi = {10.1016/j.jaci.2025.04.025}
}
EUVIMED